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Monitors Enable Medication Management in Patients’ Homes
NASA Technology 
Astronauts experience some strange things when they live and work on the International Space Station (ISS). For one, they get taller. Thanks 
to microgravity, the disks between the vertebrae of the 
spine are no longer compressed. For another, their bones 
and muscles begin to weaken because they do not have 
to work against gravity to move and conduct daily tasks; 
astronauts simply float along doing their chores and work. 
DeVon Griffin, a project manager in NASA’s Human 
Research Program at Glenn Research Center, remembers 
in the early 2000s when astronauts ran on a treadmill on 
the ISS with weight to counter these physical changes 
taking place in their bones. “The assumption was that the 
exercise should be comparable to the same kind of exer-
cise that you get from just your daily activities on Earth, 
but despite going through the motions, the astronauts 
were still losing their body’s bone mass in the weight-
bearing portions of the skeleton,” he says.
In an attempt to understand what was happening, and 
to determine what could be done to lessen the effects in 
microgravity, the National Space Biomedical Research 
Institute funded Dr. Peter R. Cavanagh, formerly of the 
Department of Biomedical Engineering at the Cleveland 
Clinic’s Lerner Research Institute, to quantify the force 
transmitted to the foot during ISS treadmill exercise. The 
goal of this effort was to try and match the daily force 
loading on the treadmill with what would be experienced 
during an average Earth day. To do this, Cavanagh 
installed pressure sensors in the shoes of astronauts. But 
the data collection capability for such a device on the ISS 
was lacking, says Griffin. “There was a need for some-
thing that could capture, store, and transmit data, but 
also be as small and lightweight as possible.”
Technology Transfer
To build a small and mobile monitoring and processing 
system for use onboard the station to capture, store, and 
transmit sensor data about astronauts back to Earth, 
Glenn awarded Small Business Innovation Research 
(SBIR) funding to Cleveland-based ZIN Technologies. 
Using those funds, ZIN developed a platform that could 
incorporate various sensors quantifying an astronaut’s 
health status and then communicate the information to 
the ground. 
“The group developed a prototype that worked,” 
says Griffin. “The device could go anywhere, and the 
technology was very adaptable.” 
For NASA, the technology could be used for virtually 
all sensors, thus allowing data collection from any device 
designed to monitor astronaut performance and health. 
On Earth, the partners envisioned it being advantageous 
for doctors to remotely monitor their patients, which is 
why ZIN partnered with the Cleveland Clinic shortly 
after demonstrating their first generation hardware.
After obtaining additional funding from Cleveland 
State University, the Global Cardiovascular Innovation 
Center, and the Ohio Third Frontier Fund, ZIN 
developed the technology further and strengthened their 
relationship with the Cleveland Clinic by forming a 
new Cleveland-based company called FlexLife Health to 
commercialize the spinoff technology.
Adequate exercise is extremely important to help astronauts maintain a healthy amount of bone and muscle mass while in space. 
Here, astronaut Sunni Williams runs on the first treadmill installed on the International Space Station (ISS). 
https://ntrs.nasa.gov/search.jsp?R=20140000079 2019-08-29T15:15:54+00:00Z
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Benefits
In late 2012, FlexLife Health launched the first version 
of the technology called vMetrics. As part of an anti-
coagulation management system for people with chronic 
cardiovascular disease, sensors paired with vMetrics were 
specifically designed to monitor the levels of anti-clotting 
agents like warfarin in a patient’s blood. These levels must 
be closely monitored because if the dosage is too high, 
there is a risk of bleeding. If the dosage is too low, the 
medication becomes less effective at preventing a possible 
blood clot.
According to Frederick J. Mindermann, CEO and 
president of FlexLife Health, “Monitoring oral anti-coag-
ulation medication can be difficult and time consuming. 
It requires frequent visits to your physician’s office to have 
blood drawn, and then wait for the clinician to advise you 
on the appropriate dosing. Now, there’s a better way to 
manage your treatment.”
vMetrics enables the monitoring of medication in real 
time at the patient’s home. After placing a blood sample 
in a separate testing instrument, data about the sample 
is automatically sent to the vMetrics device. The device 
then sends the information to FlexLife’s secure server, 
where the data is stored and can be accessed by health 
professionals or transferred to the patient’s electronic 
medical record. 
Using vMetric’s touchscreen, patients and health care 
professionals can interact—ask and answer questions—
and physicians, nurses, or pharmacists can adjust the 
patient’s dosage if necessary. 
“Patients love it because they don’t have to come into 
the clinic as often,” says Mindermann. “With a system 
like this, patients don’t have to leave the house as much.” 
In an increasingly cost-constrained medical system, saving 
money by avoiding clinic visits is an important benefit 
as well.
Based on the results of a clinical trial incorporat-
ing vMetrics, nearly 83 percent of trial participants 
reported that the technology made management of their 
medication easier and/or saved time. For these reasons, 
Mindermann is optimistic about future applications 
of the technology to monitor patients across a range of 
chronic conditions including congestive heart failure, 
hypertension, diabetes, chronic obstructive pulmonary 
disease, stroke, myocardial infarction, atrial fibrillation, 
sleep apnea, and more. 
“For someone with congestive heart failure, it is 
important to monitor weight and heart rate, and to ask 
questions about daily health,” he says. “vMetrics has an 
extensive platform that we plan to expand following this 
initial warfarin work.”
Griffin says he is happy that the space technology is 
being used on Earth, but he hasn’t ruled out the possibil-
ity of using it in space. Even though the current exercise 
program is more stringent than ever, astronauts continue 
to experience a certain amount of bone loss in space, and 
that remains a concern for long-term flights. v
vMetrics™ is a trademark of FlexLife Health.
  Patients love it because they don’t have 
to come into the clinic as often. . . . With a 
system like this, patients don’t have to leave 
the house as much.” 
—Frederick J. Mindermann, FlexLife Health
ZIN Technologies developed a device to store and transmit 
information about astronauts’ health on the ISS. The company 
then developed the system further and formed FlexLife Health 
to commercialize the technology as part of an anti-coagulation 
management system for people with cardiovascular disease.
